#Gene Expression Market

[123567-9qaaq9]

Gene Expression Analysis Market  Outlines, Future Trends, Insight And Quality Analysis 

Genes are the fundamental units of heredity, carrying instructions for the synthesis of proteins essential for various cellular functions. 

Gene expression analysis provides insights into the dynamic processes occurring within cells. It helps in identifying which genes are active, their levels of expression, and how they respond to internal and external stimuli.

The Gene Expression Analysis Market   was valued at $2,393.0 million in 2023 and is expected to reach $6,963.6 million by 2033, growing at a CAGR of 11.27% between 2023 and 2033

Gene Expression Analysis Overview 

Gene expression analysis is a field of molecular biology that investigates how genes are activated to produce functional products, such as proteins or RNA molecules, within a cell or organism. 

It encompasses a diverse range of techniques and methodologies aimed at deciphering the complex regulatory mechanisms that govern gene expression.

Market Segmentation

Segmentation 1: By Application

Segmentation 2: By End User 

Segmentation 3: By Product

Segmentation 4: By Expression System

Segmentation 5: By Region

Key Techniques used in Gene Expression 

Microarrays 

Next Generation Sequencing 

Quantitative Real Time PCR 

Download our sample page now click here !

Application for Gene Expression Analysis Market   

Disease Diagnosis and Progonosis 

Disease Discovery and Development 

Personalized Medicine 

Agricultural Biotechnology 

Key Market Players 

Agilent Technologies, Inc.

Bio-Rad Laboratories, Inc.

Charles River Laboratories International, Inc.

Danaher Corporation (Abcam plc.)

GenCefe Co., Ltd.

Genscript Biotech Corporation

And many others 

Market Dynamics

Market Drivers 

Increasing Demand for Protein Biologics Creating the Need for Protein Expression 

Market Restraints 

Long and Complicated Regulatory Timelines and Approvals of Recombinant Proteins and Biologics

Market Opportunities 

Rising Awareness of Proteomics in Emerging Countries 

 Visit our Life Sciences & Biopharma page for better understanding 

Key factors contributing to the growth of the Gene Expression Analysis Market   

Several factors influence the outcomes and methodologies of gene expression analysis:

Sample Selection

Experimental Design 

RNA Extraction and Quality  

Gene expression analysis requires careful consideration of various factors to ensure accurate, reliable, and biologically meaningful results that advance our understanding of gene regulation and function in health and disease.

Recent Developments in the Recombinant Gene Expression Analysis Market  

In January 2024, Evosep, a leader in sample preparation for mass spectrometry-based proteomics, partnered with Thermo Fisher Scientific Inc., a global scientific leader, to advance clinical proteomics research. This collaboration would combine Evosep's sample separation technology with Thermo Fisher Scientific Inc.'s mass spectrometry instruments, enhancing proteomics research capabilities.release would support pharmaceutical and biotechnology companies engaged in the manufacturing of therapeutic proteins, with the goal of improving product quality and expediting time-to-market.

Key Questions Answered 

Q What is the estimated global market size for the Gene Expression Analysis Market  ?

Q What are the future trends expected in the Gene Expression Analysis Market  ?

Q What does the supply chain and value chain of the Gene Expression Analysis Market   look like?

Q  What is the regulatory framework of the Gene Expression Analysis Market  ?

Q How has the COVID-19 outbreak affected the future trajectory of the Gene Expression Analysis Market  ?

Q What are the market entry barriers and opportunities in the Gene Expression Analysis Market  ?

Q What are the major market drivers, challenges, and opportunities of the Gene Expression Analysis Market  ?

Q How is each segment of the Gene Expression Analysis Market   expected to grow during the forecast period, and what is the anticipated revenue generated by each of the segments by the end of 2033?

Q What is the growth potential of the global Gene Expression Analysis Market   in North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World, and what are the driving and challenging factors of the market in each of these regions?

Q Who are the leading players with significant offerings in the Gene Expression Analysis Market  , and what is the current market dominance for each of these leading players? Who are the next frontiers in the Gene Expression Analysis Market  ?

Conclusion 

In conclusion, the Gene Expression Analysis Market   continues to thrive and evolve as a vital component of numerous industries, including biotechnology, pharmaceuticals, agriculture, and research

[insightslicelive]

Gene Expression Market Trends, Size Estimation, Regional Insights, Future Growth by 2032 | Agilent Technologies, GE Healthcare, Promega Corp

Gene Expression Market Trends, Size Estimation, Regional Insights, Future Growth by 2032 | Agilent Technologies, GE Healthcare, Promega Corp

The Global Gene Expression Market 2023 to 2032 report provides details of new recent developments, trade regulations, import-export intelligence, supply chain balance, share, the impact of domestic and localized market players, opportunities in terms of emerging revenue pockets, changes in market regulations, strategic growth analysis, size, category growths, application niches and dominance,…

[trendingreportz]

Genomics Market - Forecast(2024 - 2030)

Global Genomic Market Overview:

A genome is the genetic material of an organism. It includes both the genes and the noncoding DNA, as well as mitochondrial DNA and chloroplast DNA. The study of genomes is called genomics. The genomics market is gaining traction owing to its applications in various fields of study such as intragenomic phenomenon including epistasis, pleiotropy, heterosis, and other interactions between loci and alleles within the genome. In this era of medical and life science innovations shaping itself as an inevitable uptake for sustainability of mankind, the genomic research is poised for exponential growth owing to imperative genetic innovations feeding off it. Abundant potential has driven this arcade to reach a staggering market size of $16 billion - $16.5 billion as of 2018, and the demand is estimated to increment at formidable CAGR of 9.2% to 10.2% during the forecast period of 2019 to 2025.

Request Sample

Global Genomic Market Outlook:

Genomics is extensively employed in healthcare, agriculture, biotechnology, DNA sequencing, and diagnostics. In the healthcare segment, genomics is used for the development of vaccines and drugs. This segment leads the application vertical and is growing with a CAGR of 10.1%-10.7 % through to 2025. Genomics plays a significant part in diagnosis of several genetic disorders. It has an ample scope in personalized medication as it can advocate a medical management constructed on the genetic face of a person with the help of clinical data and AI.  It is also applied in synthetic biology and bioengineering. Genomics research in agriculture is hired for plant breeding and genetics to cultivate crop production. The understanding of gene function and the accessibility of genomic maps along with an enhanced understanding of genetic variant will aid the plant breeders to identify the traits and then manipulate those traits to obtain a high yield. All these factors affecting the enormous medical and agricultural sector are all set to stroke the genomics market with abundant demand.

Inquiry Before Buying

Global Genomic Market Growth Drivers:

As per the National Center for Biotechnology Information, U.S, the progression in oncology (study and treatment of tumor) expenses is forecast to rise 7%–10% annually throughout 2020, with universal oncology cost exceeding $150 billion[1]. As per the WHO, cancer is a leading cause of death worldwide, accounting for an estimated 9.6 million deaths in 2018[2]. And the total annual economic cost of cancer at the initial period of this decade was estimated at approximately $1.16 trillion. Thus the application of genomics in exploring cell-free circulating DNA by several R&D sectors as a potential biomarker for cancers is driving the market towards exponential growth. The genomics market with its current potential displays all the necessary traits it can adapt in the coming years to divert a huge chunk of traffic and revenue from the omnipresent cancer diagnostics.

As per the Food and Agriculture Organization of United Nations, between 1960 and 1990 the arable land increased by 1.5 billion ha, and in the recent past decades the elevation recorded is just 155 million ha[3]. With decreasing arable floor and the increasing global population augmenting the demand for food by 70% (by 2050), obtaining a high yield is a major trend in the agricultural sector. Genomics market is all set to capitalize on this unprecedented demand scenario. Genomics supplements the understanding of gene function and the accessibility of genomic maps along with an enhanced understanding of genetic variant, thus aiding the plant breeders to identify the traits and then manipulate those traits to obtain a high yield.

After an acute analysis of the regional insights of the global genomics market, North America is revealed to hold 39% to 40% of the entire global market size as of 2018. Such dominance can be attributed to several aspects such as cumulative investment on research by federal administrations, growing patient awareness, and accessibility of urbane healthcare facilities.

Schedule a Call

Global Genomics Market Players Perspective:

Some of other key players profiled in this IndustryARC business intelligence report are Beckton Dickson, Synthetic Genomics Inc. (SGI) ,Cepheid, Inc., Affymetrix, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, GE Healthcare, Illumina, Inc., Danaher Corporation,F. Hoffmann-La Roche, QIAGEN, Thermo Fisher Scientific and PacBio (Pacific Biosciences of California). Majority of the companies mentioned are situated in North America augmenting the regional affluence in the global market.

Global Genomics Market Trends:

High overload owing to a wide range of reagents and consumables has propelled companies into approving different policies to endure in the market and stay ahead of the curve.

For instance, in January 2017, BD launched Precise WTA Reagents for precise and guileless quantification of hereditary data form single cell analysis. Moreover, in July 2016, SGI-DNA entered into a distribution agreement with VWR International, an American company involved in the distribution of research laboratory products, with over 1,200,000 items to more than 250,000 customers in North America and Europe.

Genomics Market Research Scope

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Genomics Market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of equipment in the Genomics Market, and their specific applications in different phases of industrial operations.

Buy Now

Genomics Market Report: Industry Coverage

Types of Solutions Genomics Market:

By Product Types- Microarray chip, Sequencers.

By Application- Genotyping, SNP analysis.

By End-User- Anthropology, Diagnostics.

The Genomics Market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

North America: The U.S., Canada, Mexico

South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

Middle East and Africa: Israel, South Africa, Saudi Arabia

[marketreports-blog]

According to recent study by nova one advisor, the global gene expression market size was valued at USD 14.91 billion in 2023 and is poised to exceed USD 24.53 billion by 2033, expanding at a CAGR of 5.1% between 2024 and 2033.

[cmipooja]

Global Third Generation Sequencing Market Is Estimated To Witness High Growth Owing To Increasing Demand for Personalized Medicine

The global Third Generation Sequencing market is estimated to be valued at US$ 8.93 Bn in 2022 and is expected to exhibit a CAGR of 13.1% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Third Generation Sequencing refers to a new generation of DNA sequencing technologies that have revolutionized genomics research. Unlike traditional sequencing methods, third generation sequencing provides long-read sequencing capabilities, high accuracy, and reduced operational costs. These advancements have made it an essential tool in various applications such as personalized medicine, oncology research, agriculture, and microbiology. Third generation sequencing allows researchers to obtain more comprehensive and accurate genetic information, leading to better understanding of diseases and personalized treatment options. Market Key Trends: One key trend driving the growth of the Third Generation Sequencing market is the increasing demand for personalized medicine. With advancements in genomic analysis, personalized medicine has gained significant attention in recent years. Third generation sequencing plays a crucial role in providing accurate and detailed information about an individual's genetic makeup, enabling healthcare professionals to tailor treatment plans based on the specific needs of each patient. This trend is expected to drive the adoption of third generation sequencing technologies in healthcare settings. For example, Pacific Biosciences of California, Inc., one of the key players in the market, offers the PacBio Sequencing System that provides long-read sequencing capabilities, enabling researchers to explore complex genetic variations associated with diseases. The system has been widely used in oncology research to understand tumor heterogeneity and identify potential therapeutic targets. PEST Analysis: Political: The use of third generation sequencing technologies is subject to government regulations and policies related to privacy, data protection, and ethical considerations. Regulatory frameworks vary across different regions, which may impact the adoption and commercialization of these technologies. Economic: The increasing investment in genomics research and the growing demand for personalized medicine are driving the economic growth of the Third Generation Sequencing market. The market is expected to witness significant investments in research and development activities aimed at improving the speed, accuracy, and cost-effectiveness of sequencing technologies. Social: The rising awareness about genetic predispositions to diseases and the importance of personalized medicine is shaping social attitudes towards genomics research and sequencing technologies. Growing acceptance of genetic testing and personalized treatments is expected to drive the demand for third generation sequencing in healthcare settings. Technological: Continuous advancements in sequencing technologies, such as improvements in throughput, accuracy, and read length, are driving the growth of the Third Generation Sequencing market. Technological advancements, such as nanopore sequencing technology offered by Oxford Nanopore Technologies, Ltd., provide portable, real-time sequencing capabilities, making sequencing more accessible and cost-effective. Key Takeaways: Market Size Related Content: The Global Third Generation Sequencing Market Growth is expected to witness high, exhibiting a CAGR of 13.1% over the forecast period. This growth can be attributed to increasing demand for personalized medicine. Personalized medicine relies on accurate genetic information obtained through third generation sequencing, enabling healthcare professionals to tailor treatment plans based on individual patient needs.

[market-insider]

Gene Expression and Precision Medicine: Market Developments and Future Directions

Gene expression refers to the process by which the information encoded in a gene is used to create a functional gene product, such as a protein or a functional RNA molecule. It involves a series of molecular events that occur within a cell, ultimately leading to the production of the gene's encoded product. The process of gene expression starts with the transcription of the gene's DNA sequence into a complementary RNA molecule, called messenger RNA (mRNA). This process occurs in the cell nucleus and is catalyzed by an enzyme called RNA polymerase. The mRNA molecule then undergoes a series of modifications, including the removal of non-coding regions called introns and the addition of a protective cap and a tail.

Gain deeper insights on the market and receive your free copy with TOC now @: Gene Expression Market Report

Following mRNA processing, the mature mRNA molecule is transported out of the nucleus and into the cytoplasm, where it serves as a template for translation. Translation is the process by which the mRNA sequence is decoded by ribosomes to synthesize a specific protein. The ribosomes read the mRNA codons and assemble the corresponding amino acids into a polypeptide chain, which folds into a functional protein. The regulation of gene expression is crucial for the proper functioning and development of organisms. It allows cells to respond to different signals and adapt to changing environments. Gene expression is tightly controlled at various levels, including transcriptional regulation, post-transcriptional regulation, translational regulation, and post-translational modifications. These mechanisms ensure that genes are expressed at the right time, in the right cells, and in the right amounts.

Next-Generation Sequencing (NGS) technologies have revolutionized gene expression analysis by allowing high-throughput sequencing of RNA molecules. This has facilitated the discovery of novel transcripts, identification of differentially expressed genes, and exploration of alternative splicing events. NGS-based platforms, such as RNA-Seq, have become widely adopted for transcriptome profiling. The ability to study gene expression at the single-cell level has provided unprecedented insights into cellular heterogeneity and gene regulatory networks. Single-cell RNA sequencing (scRNA-seq) technologies have emerged, enabling the profiling of gene expression in individual cells and uncovering cell subtypes, rare cell populations, and dynamic cellular states.

Integrating gene expression data with other omics datasets, such as genomics, epigenomics, and proteomics, has gained attention. By combining multiple layers of molecular information, researchers can gain a more comprehensive understanding of gene regulation, interactions, and signaling pathways. The increasing complexity and volume of gene expression data have led to the development of sophisticated bioinformatics and computational tools. These tools aid in data preprocessing, normalization, differential expression analysis, pathway analysis, and functional enrichment, enabling researchers to extract meaningful insights from large-scale gene expression datasets. Gene expression profiling has been instrumental in drug discovery and development. By examining the gene expression patterns in diseased tissues or cells, researchers can identify potential drug targets and biomarkers for patient stratification and personalized treatment approaches. The demand for gene expression assays, including quantitative polymerase chain reaction (qPCR) and microarray-based technologies, remains strong. These assays continue to be widely used due to their simplicity, cost-effectiveness, and ability to provide targeted gene expression information.

[navabharatlive]

Gene Expression Analysis Market Report Insights and Industry Analysis by Product (Consumables & Instruments), Service (Gene Expression Profiling & Others), Application (Drug Discovery & Others), End User (Academic & Research Institutes & Others), and Region, Competitive Market Size, Share, Trends, and Forecast, 2018-2023

[rock-and-roll-hell]

April 28, 1977

Love Gun Photo Sessions

Barry Levine’s Studio - Los Angeles, California

📸 Barry Levine

"We experimented a lot with everything. That’s how the series with the wildly multicolored, shimmering mylar background happened. It was 1977 and we had to do a Love Gun promotional shoot. I set it up in my studio and I wanted to get a series with different colors in the background because we had been using a lot of blacks and greys up to that point. I got these colored mylar sheets and reflected some plain white light from them, sometimes adding just a little bit of blue gel to the mix. I pulled the light a little out of focus because the patterns on the sheets were very odd, and I wanted to get really vibrant colors and images from the mylar. These shots appeared on magazines and newspapers all over the place. Some mylar shots, as well as other images I photographed, were included on the cover of KIϟϟ’ World Tour 77-78 program. If you look really carefully, you can tell that those same shots were the photo models for the gatefold etchings inside Double Platinum, as well as the solo album covers, although we didn’t have either of those projects in mind when we decided to shoot that day

Although I had shot many bands before KIϟϟ, I knew the second they stepped into my studio, they were in a class by themselves. Techniques that worked with other bands, didn’t fly with KISS. And the difference in style between individual members was vast. I quickly became familiar with their distinct personalities and became adept at pulling certain traits out of each of them as needed. When they’re onstage, they simply metamorphosize into their unique band personas, but in the studio, it was up to me to pull a Demon, a Spaceman, a Lover and a Cat out of the four guys who showed up. They all knew how to capture their onstage personas, but sometimes I had to go the extra mile to get just the right facial expression or stance.” - Barry Levine

KIϟϟ’ new costumes (Love Gun) were constructed by Maria Contessa and Laurie Greenan, and the band traveled with three of each of the outfits while on tour. Gene and Ace used slightly altered versions of the original design for touring purposes. The total cost for the new production, including the new stage, costumes and instruments, was $194,910, although the show was hyped as a million-dollar production in most markets.

[123567-9qaaq9]

Protein Expression Market to Witness Massive Growth Forecast to 2023-2033

Proteins, often referred to as the building blocks of life, are fundamental to nearly every biological process. From enzymes that catalyze biochemical reactions to signaling molecules that regulate cellular activities, proteins are indispensable. Protein expression is the process by which the genetic information encoded in DNA is translated into functional proteins within a cell.

The Global Protein Expression Market was valued at $2,393.0 million in 2023 and is expected to reach $6,963.6 million by 2033, growing at a CAGR of 11.27% between 2023 and 2033

Protein Expression Overview 

In the pharmaceutical and biotechnology industries, protein expression is a critical component of drug discovery and development. Recombinant proteins are used as therapeutic agents themselves, such as insulin for diabetes or monoclonal antibodies for cancer treatment. Additionally, proteins are utilized in the production of vaccines, diagnostics, and biologics manufacturing processes. The ability to express proteins with high yields, purity, and biological activity is paramount for ensuring the efficacy and safety of these products.

Market Segmentation

Segmentation 1: By Application

Segmentation 2: By End User 

Segmentation 3: By Product

Segmentation 4: By Expression System

Segmentation 5: By Region

Download our sample page now click here !

Applications Across the Scientific Landscape

The importance of protein expression transcends the boundaries of basic research, permeating diverse fields such as biotechnology, medicine, and industrial applications. In biopharmaceuticals, recombinant protein expression serves as the cornerstone of drug discovery and development, enabling the production of therapeutic proteins, antibodies, and vaccines.

Key Market Players 

Agilent Technologies, Inc.

Bio-Rad Laboratories, Inc.

Charles River Laboratories International, Inc.

Danaher Corporation (Abcam plc.)

GenCefe Co., Ltd.

Genscript Biotech Corporation

And many others 

Recombinant Protein Expression Market 

Recombinant protein expression is a testament to humanity's ingenuity in leveraging the natural machinery of cells to fulfill our scientific and commercial needs. At its core, the process involves introducing foreign DNA sequences – encoding the desired protein of interest – into host organisms such as bacteria, yeast, insect cells, or mammalian cells. Through the process of transcription and translation, these host cells become miniature protein factories, faithfully churning out the specified proteins with remarkable fidelity.

Visit our Life Sciences & Biopharma page for better understanding 

Gene Expression is the process by which the information encoded within our genes is converted into functional molecules – primarily proteins and non-coding RNAs – that carry out the myriad functions of living organisms. This process unfolds in two main stages: transcription and translation. During transcription, the DNA sequence of a gene is transcribed into a complementary messenger RNA (mRNA) molecule by the enzyme RNA polymerase.

In the dynamic landscape of biotechnology, protein production technologies play a pivotal role in unlocking the potential of proteins for a myriad of applications, ranging from therapeutics and diagnostics to industrial enzymes and biopolymers.

Recent Developments in the Protein Expression Market

•In January 2024, Evosep, a leader in sample preparation for mass spectrometry-based proteomics, partnered with Thermo Fisher Scientific Inc., a global scientific leader, to advance clinical proteomics research. This collaboration would combine Evosep's sample separation technology with Thermo Fisher Scientific Inc.'s mass spectrometry instruments, enhancing proteomics research capabilities. •In July 2023, Lonza Bioscience introduced the TheraPRO CHO Media System, a novel cell culture platform designed to streamline processes and enhance productivity and protein quality, particularly when used in conjunction with GS-CHO cell lines. This release would support pharmaceutical and biotechnology companies engaged in the manufacturing of therapeutic proteins, with the goal of improving product quality and expediting time-to-market.

Key Questions Answered 

Q What is the estimated global market size for the protein expression market?

Q What are the future trends expected in the protein expression market?

Q What does the supply chain and value chain of the protein expression market look like?

Q  What is the regulatory framework of the protein expression market?

Q How has the COVID-19 outbreak affected the future trajectory of the protein expression market?

Q What are the market entry barriers and opportunities in the protein expression market?

Q What are the major market drivers, challenges, and opportunities of the protein expression market?

Q How is each segment of the protein expression market expected to grow during the forecast period, and what is the anticipated revenue generated by each of the segments by the end of 2033?

Q What is the growth potential of the global protein expression market in North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World, and what are the driving and challenging factors of the market in each of these regions?

Q Who are the leading players with significant offerings in the protein expression market, and what is the current market dominance for each of these leading players? Who are the next frontiers in the protein expression market?

Conclusion 

Despite the significant advancements in protein expression technologies, several challenges persist, including the optimization of protein yields, the cost-effectiveness of production processes, and the scalability of manufacturing operations. Additionally, the complexity of mammalian expression systems poses challenges in terms of cell line development, process optimization, and regulatory compliance.

[cryptovalid]

The politics of Operation Zero Tolerance

If you've followed X-men '97, you know that's it's more than competently executed nostalgia-bait. It's a deconstruction of the original ideological framework of the X-men. I'll be riffing off of the way that Operation Zero Tolerance mirrors real world alt-right ideology and where the show might lead this theme. Spoilers ahead up to episode 8. It's a long one.

So the reflections of the January 6th insurrection, Great Replacement conspiracy and stochastic terrorism are pretty spot on. But what do the Prime candidates actually believe?

Mutants are constantly referred to as 'the next step in human evolution'. This frightens some non-mutants, who see themselves being replaced. Their solution is to subjugate mutants.

I want to focus on some of the ways this doesn't make sense first.

1. Evolution doesn't have well defined 'next steps': every new generation is slightly different from the previous, so that over time new traits will emerge and become common, and others will become less widespread. In the comics, this is not why mutants exist: the are the result of alien tampering with human dna: the Celestials implanted the X-gene in some humans. So 'mutants' are demonstrably just a strain of humanity, and the main reason humans have mutant babies is that their own genes are getting expressed in a new way.

2. No amount of control or violence can stop this. The rate at which mutants appear isn't even dependent on their own reproductive success since most mutants have human parents.

We don't know why more and more mutants are being born now, but OZT will not stop this. It's not even their goal. When they say human being are being 'replaced', they actually mean replaced as the ruling class of the planet. Bastion's 'utopia' doesn't have less mutants being born, just used as slave labor.

This really puts the anxiety of OZT into focus: they want to maintain privilege. They aren't really being 'replaced', any more than older generations are always 'replaced' by younger generations. They are primarily afraid that mutants will render them obsolete in the labor market. But if mutants can be forced to do unpaid labor for their benefit, that doesn't threaten them.

The way this parallels the rhetoric of the alt right is striking. Obviously, the reasons why jobs are moving overseas are different: colonized populations are more exploitable by capital. But the fears are the same: my children are different from me, and if I'm not valued for my labor, I will become poor. Like OZT, the alt right also chooses to enact violence even though it won't solve either of these issues. the MAGA-crowd threatens non-conformity and asserts its dominance to maintain its relative privilege over other groups. This is why it's all culture war stuff. The alt right isn't interested in striking to improve conditions for workers, it will attack immigrants and minorities they perceive as competition. Never the bosses that make the hiring decisions. It's scapegoating.

Even child and slave labor are on the table. Because again, this 'economic anxiety' isn't triggered by other people doing the work, just by other people getting money, care and respect that they feel they are owed.

It's not the solution that matters to OZT or the alt right: it's the catharsis of violence and control. It's interesting that OZT actually has a better point: mutants are inherently better at some jobs, some mutants ARE inherently dangerous. Their anxiety is way more warranted.

And I think that is what makes OZT hit so hard as an allegory: it is a steel man version of every bigot's rhetoric, and it is horrifying.

Where might the show take this theme? I don't think the show will end with the X-men fighting Magneto, as that would undermine the show's thematic support for his ideals. Magneto might be defeated, but that will not be the finale. I think the institutional support for OZT will be the closing statement.

The events of episode 8 will be blamed on the X-men. There's just too many ways that a sleeper that Wolverine cut to ribbons can be spun and Bastion has stated multiple times that he understands the optics of martyring mutants. In my opinion this explains how the primes failed to kill a single X-man, even though Trask could take down the whole team.

This twist will (I think) be used to set up the Avengers as the final threat: the X-men try to reason with Magneto, the Avengers attack him, and maybe Xavier erases Magneto's memory as a prelude to Onslaught.

Onslaught can then lead into Heroes Reborn; when Onslaught threatens to kill the Avengers and Fantastic Four, Franklin Richards creates a parallel universe, where they live out their lives in blissfull ignorance of mutants. I believe this could explain why the MCU does not have mutants: it's the Heroes Reborn Universe (The FF could live in a separate universe).

So how to put a button on OZT? I don't think that they will end as a political force (these ideas will remain relevant in the fiction as in the real world). I think the show will obviously set up a fight with Bastion, but the ideological refutation will have to come from Mrs. Da Costa. She is the poster child of an apathetic liberal, who will only support mutants in fashionable ways. If she ends the series giving up her social status to save her son, perhaps even dying, it will thematically reinforce the need for allies to be traitors of their own privilege.

This ties in with my final speculation. This is a weird one and a reach. We have not seen Roberto Da Costa's father. We also don't know where Bastion's father is (who is essentially Nimrod). Is it possible that they are half-brothers? Emmanuel Da Costa is a prominent anti-mutant member of the Hellfire Club, and it's strange he hasn't shown up yet. Honestly, this could possibly explain why Roberto is so light-skinned. Which I do not want to make excuses for otherwise.

[insightslicelive]

Gene Expression Market is experiencing boost at an infinite speed By 2032 | Agilent Technologies, GE Healthcare, Promega Corp

Gene Expression Market is experiencing boost at an infinite speed By 2032 | Agilent Technologies, GE Healthcare, Promega Corp

A recent market research report added to repository of insightSLICE is an in-depth analysis of Global Gene Expression  Industry. On the basis of historic growth analysis and current scenario of Gene Expression  industry place, the report commits to offer actionable insights for the industry participants. Authenticated data presented in report is based on exhaustive primary and secondary research.…

[omg-snakes]

So, do all diffused corn snakes have to have patternless sides or is it another gene that can have levels of expression? I'm buying a pewter corn hatchling soon but it has those patterns. And another completely unrelated question (didn't want to send 2 asks) but lets say one snake is het for charcoal and the other snake its being paired to is not het for charcoal. Does that het pass on to the hatchling at all?

Hello friend!

Diffused corn snakes should have some level of diffusion of pattern on their sides (that's where the name comes from!) that gets more pronounced closer to the tummy, but there are definitely levels of quality at play. A snake with no or very light side patterning is obviously going to be a higher quality Diffused than one with more normal-type side patterning. It's become pretty common to see these popping up in the hobby, though, as folks just mash snakes together without regard for morph integrity. :(

Personally, I know "pet only" is a bit of a trigger phrase in the reptile hobby, but if a Diffused has normal, undiffused patterning on their sides or any checkering on their tummy, I certainly wouldn't consider them worth breeding. They can still be a gorgeous lovely pet! There's absolutely nothing wrong with keeping snakes as pets and just, like, not breeding them! You don't need to breed them to love them! You don't need to breed them please stop breeding them I beg of you please the market is so saturated please do not

Anyway,

If a het [insert favorite gene here] is paired to a non-het, the resulting offspring will be 50% likely to carry the het gene. We call these "50% het [gene name]" until proven het or non-het.

[accihoe]

Birthday Boy

Pairing: Draco Mlalfoy x fem!reader

Summary: self explanatory

Warnings: old Draco (jokes), oc Draco? Super short. Not proofread. I love all of you and i promise more and better stories later.

A/n: this is extremely rushed, ily old man

(gif not mine)

He awoke with a kiss to his forehead and her covering him up properly with the sheets, as it was a warm summer morning. He then feel asleep again, only to be woken up by signing. His beloved, in that pretty summery dress of hers, Scorpius in his pyjamas, and his other two children in their pyjamas as well. His youngest assisted him in blowing out the candles on his bran muffin.

The morning was filled with snuggling and coddling whilst his beloved Y/N prepared breakfast. He had breakfast in bed whilst his children got ready. "Happy birthday, my darling." His wife of 18 years said, kissing his forehead as she stroked the hair out of his face. He opened his gifts, hand wrapped by his wife and children. Over the moon with each gift.

In the noon the family went for lunch at their favourite cafe where the waiters prepared a stupid ice-cream cake with firework candles for him, he adored it. His wife even more so as she snapped several photographs. After the celebration the family visited a market for fruit, green apples specifically, as Draco's children had all miraculously inherited his granny apple loving genes.

Late noon Draco and Y/N's parents came over for a celebratory supper. Once the kids were put to bed his wife expressed her love for him yet again and they were united as husband and wife during passionate hours. The following January, Y/N presented him with a gift, a rather loud one. Exactly like a baby mandrake without the mandrake.

...

Please don't steal my work.

Happy 43rd old man, ily.

[chussyracing]

what has been happening in the world of motorsports lately?

(i am super late with all the news, so i'm putting the massive amount of text under the cut)

DRIVER (and engineer) MARKET

Adrian Newey leaving RBR (there are a lot of question marks like if he will get 12 months of gardening leave since the day he hands in his resignation or if he is hired by the team on external contract as they tried to avoid putting him under budget cap; how much it's linked to the tensions in RBR concerning Horner staying in the lead of the team despite being under investigation - that could mean other team members leaving; there is a rumour that Horner also refused to get paddock tickets for Adrian Newey's partner Amanda last year and the relationship has been broken ever since; he could go to Ferrari and there are reports he was offered 100 million pounds with an ambassador role; Toto Wolff is also interested in him and in Max, he is set to meet with his side and with Ola Kallenius from Merc and Jim Ratcliffe from Ineos after Miami about rumoured 150 million Euros contract; there are also questions about exit clauses for Max, Adrian and Helmut Marko; there are other questions like whether he wants to stay in the UK - although Daily Mail says Amanda is already looking at houses in Italy - and whether he would like to retire from F1 altogether; and final note to this point: Craig Slater said he spoke to Aston Martin insiders and found out Newey declined AM's lucrative offer and they think he is heading to Ferrari)

Nico Hulkenberg is set to leave Haas at the end of the year and joing Sauber on multi-year contract (German media reports it is 3-years contract), it's preparation for the Audi move

Ollie Bearman is rumoured to join Haas instead

Sam Bird injured himself in practice for Monaco Eprix which allowed Taylor Barnard to jump into the car

Kimi Antonelli is still linked to Mercedes and William's seat, he just finished W12 testing in Austria at Red Bull Ring (although his test was hindered by the weather, if you live close you know our weather went from 30 degrees Celsius to snowing and below zero) and today he tested W13 in Imola as well

Horner is still pushing for Ricciardo to the second RBR seat but highlighted to achieve that, he would need to improve his form drastically, he also suggested that Liam Lawson doesn't have a seat guaranteed if he even gets into F1 to which Helmut Marko remarked that Liam Lawson has an exit clause if Red Bull doesn't find a seat for him for next year in F1

at the start of the month, journalist Joe Saward reported that Logan could get replaced by Kimi Antonelli after Miami (I won't go into detail but there is multiple reasons why this is highly unlikely)

F1 Academy's first champion Marta Garcia tested with ERT during Formula E rookie test in Berlin

there are rumours about Mick Schumacher being in talks with Prema's Indycar seat

Guenther Steiner is rumoured to buy a team (or shares in a team) in F1, because reportedly the main reason he was let go of by Haas was him founding a huge sponsor for the team and offering it to Gene Haas in exchange for shareholding in the team - now he wants to take the money elsewhere

Jessica Edgar in F1 Academy scored American Express sponsorship, so she will be changing race suit into their dark blue color - and possibly also her livery

Marko Helmut hinted they want to extend Checo Perez's contract but they aren't ready to give him 3 years long extension he is asking for

David Croft said that Gasly is in talks with Williams for 2025 seat, Sainz to Audi is probable but the talks are postponed to mid-May (and Yuki and Esteban are also in talks with them) and that he thinks Guanyu will be left without a seat for 2025

McLaren's Indycar team dropped David Malukas after his hand injury (which relates closely to what I previous said about Callum Illot and Theo Pourchaire jumping in for him, I expect Theo to be named their full time driver)

Lawrence Stroll was looking to sell AM to a big name (so probably Aramco) but his condition was to keep Lance and they didn't agree so the deal fell under the table, on the other hand Honda who is set to join them in 2026 and said to immediately target the title are happy with Lance

SPONSORSHIPS AND INVESTORS

Ferrari introduced HP as their new title sponsor making them Scuderia Ferrari HP (the contract is rumouredly between 80 to 100 mil per year which is bigger than ORACLE) 🤢 - the sponsorship is for F1 Academy and Ferrari Esports teams as well

Hockenheim scored new investors who came with 250 mil Euros injection for the circuit for repairs and changes which could help it reclaim its place at F1's calendar (Thailand and South Korea are also looking to get a place on the calendar)

Lawrence Stroll is rumouredly looking to sell 25% shares in AM

Guanyu became ambassador for Beef Burger McDonald's China

this is actually month old news by SportsRush who reported that Dutch media posted it was Helmut Marko who advised Ford to pull out of the RBR sponsorship deal

Mastercard is in talks with 4 F1 teams for a title sponsor deal and apparently McLaren is the strongest candidate at this point

NEWS FOR MIAMI

Ferrari are bringing blue livery, helmets, suits, merch and GT cars to Miami as US heritage of Ferrari (they are two different shades of blue and it could also be a marketing move in preparation for the HP sponsorship that was announced a day later)

trophies by Miami GP were made by Tiffany and they were inspired by the architecture of Hard Rock Stadium

multiple teams are bringing (mostly smaller) upgrades for Miami: RB, McLaren, Mercedes, Williams

Miami GP organizers banned Trump presidental fundaraiser from the paddock

Alex will have Albon Athletics even this Wednesday in Miami in Legends Miami sneaker store

Williams is also opening a Fan Zone with drivers present

multiple teams are are bringing new merch collections: besides Ferrari, it's also McLaren, Red Bull, Williams or official F1 merch

Andretti continues hiring in all areas and are set to meet with F1 Management to discuss their F1 entry in Miami

multiple drivers already showed their special helmets with more probably to follow: Ferrari drivers, Max for all US races and Oscar

Niki Lauda's 1976 helmet from the infamous incident is going into auction in Miami

team principals will meet to discuss jump starts and how they should be judged in Miami

OTHER MOTORSPORTS SERIES

Mitch Evans won the Monaco Eprix and the team achieved 1-2 with Nick in p2

Formula E also launched GEN3 Evo before the Eprix

6 hours of Imola in WEC was won by Nyck de Vries' team although it was Ferrari 1-2-3 during quali (then Ferrari strategy strategied)

F1 Academy in Zadvoort and F2 in Barcelona finished their in-season testing (Abbi Pulling was fastest in F1 Academy and Isack Hadjar was fastes in F2)

the first Autonomous Racing League race = AI took place in Yas Marina (and you need to read it for yourself because my report wouldn't do it justice)

THE FUTURE OF F1

F1 is discussing revised point system where two more people could score (so points from p1 to p12), but the introduction was delayed and they will report on this more towards the end of the year after they collect more data

F1 commision agreed on introducing rear facing cameras from Spain onwards

Aston Martin exposed a grey area in rules when they protested Carlos stopping on track in China and FIA is exposed to clear it up to probably set a time limit when the driver has to restart the car, otherwise they won't be able to continue in the session

Domenicali told FormulaPassion that if drivers are complaining about the number of races and sprints, they are not mandatory to race (it was also a response to reports that he wants to add more sprints to the calendar)

F1 introduced new free streaming station in the US which should allowed viewers to follow F1 and junior series as well as some exclusive content

F1 reduced its carbon footprint by 13% since 2018 as per their 2023 impact report and they want to continue towards zero emissions promise by 2030

WHAT HAPPENED OFF TRACK

Irish Sun says that the victim of Horner's inappropriate behaviour hired a new legal team, she has been questioned a lot for the appeal these days, but she could get peace soon as it should get sorted by the middle of May

Grill the Grid team posted a new F1 video "Anything but F1"

Max was named one of the 100 most influential people of 2024

EA Sports released F1 24 and F1 24 Champions covers

Vogue Italy's new issue features a photoshoot including Irina Shyak and Ferrari drivers and engineers

Mercedes became the first F1 team to reach over 500m pounds turnover

Imola will be remembering Senna and Ratzenberger this week for their 30th anniversary

Valtteri the chaotic king he is, qualified for a cycling championship

Lando was apparently celebrating King's Day in Neatherlands so hard that he cut his noce on a broken glass